Developing Patient-Centered Treatment Protocols in Brain Stimulation: A Rationale for Combining Quantitative and Qualitative Approaches in Persons With HIV

Mary Rosedale, Dolores Malaspina, Daniel Malamud, Shiela M. Strauss, Jaclyn D. Horne, Salman Abouzied, Ricardo A. Cruciani, Helena Knotkova

Research output: Contribution to journalArticle

Abstract

This article reports and discusses how quantitative (physiological and behavioral) and qualitative methods are being combined in an open-label pilot feasibility study. The study evaluates safety, tolerability, and acceptability of a protocol to treat depression in HIV-infected individuals, using a 2-week block of transcranial direct current stimulation (tDCS) over the dorsolateral prefrontal cortex. Major depressive disorder (MDD) is the second most prevalent psychiatric disorder after substance abuse among HIV-positive adults, and novel antidepressant treatments are needed for this vulnerable population. The authors describe the challenges and contributions derived from different research perspectives and methodological approaches and provide a philosophical framework for combining quantitative and qualitative measurements for a fuller examination of the disorder. Four methodological points are presented: (1) the value of combining quantitative and qualitative approaches; (2) the need for context-specific measures when studying patients with medical and psychiatric comorbidities; (3) the importance of research designs that integrate physiological, behavioral, and qualitative approaches when evaluating novel treatments; and (4) the need to explore the relationships between biomarkers, clinical symptom assessments, patient self-evaluations, and patient experiences when developing new, patient-centered protocols. The authors conclude that the complexity of studying novel treatments in complex and new patient populations requires complex research designs to capture the richness of data that inform translational research.

Original languageEnglish (US)
Pages (from-to)166-174
Number of pages9
JournalJournal of the American Psychiatric Nurses Association
Volume18
Issue number3
DOIs
StatePublished - May 2012

Fingerprint

Clinical Protocols
HIV
Brain
Psychiatry
Research Design
Diagnostic Self Evaluation
Translational Medical Research
Symptom Assessment
Major Depressive Disorder
Feasibility Studies
Vulnerable Populations
Prefrontal Cortex
Antidepressive Agents
Substance-Related Disorders
Comorbidity
Therapeutics
Biomarkers
Depression
Safety
Research

Keywords

  • biomarkers
  • HIV
  • patient-centered treatment
  • tDCS
  • transcranial direct current stimulation

ASJC Scopus subject areas

  • Phychiatric Mental Health

Cite this

Developing Patient-Centered Treatment Protocols in Brain Stimulation : A Rationale for Combining Quantitative and Qualitative Approaches in Persons With HIV. / Rosedale, Mary; Malaspina, Dolores; Malamud, Daniel; Strauss, Shiela M.; Horne, Jaclyn D.; Abouzied, Salman; Cruciani, Ricardo A.; Knotkova, Helena.

In: Journal of the American Psychiatric Nurses Association, Vol. 18, No. 3, 05.2012, p. 166-174.

Research output: Contribution to journalArticle

Rosedale, Mary ; Malaspina, Dolores ; Malamud, Daniel ; Strauss, Shiela M. ; Horne, Jaclyn D. ; Abouzied, Salman ; Cruciani, Ricardo A. ; Knotkova, Helena. / Developing Patient-Centered Treatment Protocols in Brain Stimulation : A Rationale for Combining Quantitative and Qualitative Approaches in Persons With HIV. In: Journal of the American Psychiatric Nurses Association. 2012 ; Vol. 18, No. 3. pp. 166-174.
@article{83c2f900bcbe4a5381fc9507f26878f8,
title = "Developing Patient-Centered Treatment Protocols in Brain Stimulation: A Rationale for Combining Quantitative and Qualitative Approaches in Persons With HIV",
abstract = "This article reports and discusses how quantitative (physiological and behavioral) and qualitative methods are being combined in an open-label pilot feasibility study. The study evaluates safety, tolerability, and acceptability of a protocol to treat depression in HIV-infected individuals, using a 2-week block of transcranial direct current stimulation (tDCS) over the dorsolateral prefrontal cortex. Major depressive disorder (MDD) is the second most prevalent psychiatric disorder after substance abuse among HIV-positive adults, and novel antidepressant treatments are needed for this vulnerable population. The authors describe the challenges and contributions derived from different research perspectives and methodological approaches and provide a philosophical framework for combining quantitative and qualitative measurements for a fuller examination of the disorder. Four methodological points are presented: (1) the value of combining quantitative and qualitative approaches; (2) the need for context-specific measures when studying patients with medical and psychiatric comorbidities; (3) the importance of research designs that integrate physiological, behavioral, and qualitative approaches when evaluating novel treatments; and (4) the need to explore the relationships between biomarkers, clinical symptom assessments, patient self-evaluations, and patient experiences when developing new, patient-centered protocols. The authors conclude that the complexity of studying novel treatments in complex and new patient populations requires complex research designs to capture the richness of data that inform translational research.",
keywords = "biomarkers, HIV, patient-centered treatment, tDCS, transcranial direct current stimulation",
author = "Mary Rosedale and Dolores Malaspina and Daniel Malamud and Strauss, {Shiela M.} and Horne, {Jaclyn D.} and Salman Abouzied and Cruciani, {Ricardo A.} and Helena Knotkova",
year = "2012",
month = "5",
doi = "10.1177/1078390311436128",
language = "English (US)",
volume = "18",
pages = "166--174",
journal = "Journal of the American Psychiatric Nurses Association",
issn = "1078-3903",
publisher = "SAGE Publications Inc.",
number = "3",

}

TY - JOUR

T1 - Developing Patient-Centered Treatment Protocols in Brain Stimulation

T2 - A Rationale for Combining Quantitative and Qualitative Approaches in Persons With HIV

AU - Rosedale, Mary

AU - Malaspina, Dolores

AU - Malamud, Daniel

AU - Strauss, Shiela M.

AU - Horne, Jaclyn D.

AU - Abouzied, Salman

AU - Cruciani, Ricardo A.

AU - Knotkova, Helena

PY - 2012/5

Y1 - 2012/5

N2 - This article reports and discusses how quantitative (physiological and behavioral) and qualitative methods are being combined in an open-label pilot feasibility study. The study evaluates safety, tolerability, and acceptability of a protocol to treat depression in HIV-infected individuals, using a 2-week block of transcranial direct current stimulation (tDCS) over the dorsolateral prefrontal cortex. Major depressive disorder (MDD) is the second most prevalent psychiatric disorder after substance abuse among HIV-positive adults, and novel antidepressant treatments are needed for this vulnerable population. The authors describe the challenges and contributions derived from different research perspectives and methodological approaches and provide a philosophical framework for combining quantitative and qualitative measurements for a fuller examination of the disorder. Four methodological points are presented: (1) the value of combining quantitative and qualitative approaches; (2) the need for context-specific measures when studying patients with medical and psychiatric comorbidities; (3) the importance of research designs that integrate physiological, behavioral, and qualitative approaches when evaluating novel treatments; and (4) the need to explore the relationships between biomarkers, clinical symptom assessments, patient self-evaluations, and patient experiences when developing new, patient-centered protocols. The authors conclude that the complexity of studying novel treatments in complex and new patient populations requires complex research designs to capture the richness of data that inform translational research.

AB - This article reports and discusses how quantitative (physiological and behavioral) and qualitative methods are being combined in an open-label pilot feasibility study. The study evaluates safety, tolerability, and acceptability of a protocol to treat depression in HIV-infected individuals, using a 2-week block of transcranial direct current stimulation (tDCS) over the dorsolateral prefrontal cortex. Major depressive disorder (MDD) is the second most prevalent psychiatric disorder after substance abuse among HIV-positive adults, and novel antidepressant treatments are needed for this vulnerable population. The authors describe the challenges and contributions derived from different research perspectives and methodological approaches and provide a philosophical framework for combining quantitative and qualitative measurements for a fuller examination of the disorder. Four methodological points are presented: (1) the value of combining quantitative and qualitative approaches; (2) the need for context-specific measures when studying patients with medical and psychiatric comorbidities; (3) the importance of research designs that integrate physiological, behavioral, and qualitative approaches when evaluating novel treatments; and (4) the need to explore the relationships between biomarkers, clinical symptom assessments, patient self-evaluations, and patient experiences when developing new, patient-centered protocols. The authors conclude that the complexity of studying novel treatments in complex and new patient populations requires complex research designs to capture the richness of data that inform translational research.

KW - biomarkers

KW - HIV

KW - patient-centered treatment

KW - tDCS

KW - transcranial direct current stimulation

UR - http://www.scopus.com/inward/record.url?scp=84862531252&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84862531252&partnerID=8YFLogxK

U2 - 10.1177/1078390311436128

DO - 10.1177/1078390311436128

M3 - Article

C2 - 22412085

AN - SCOPUS:84862531252

VL - 18

SP - 166

EP - 174

JO - Journal of the American Psychiatric Nurses Association

JF - Journal of the American Psychiatric Nurses Association

SN - 1078-3903

IS - 3

ER -